pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
CRD-002
Spinocerebellar Ataxia (SCA)
Cure Rare Disease
0
catalysts
Preclinical
CRD-003
Limb-Girdle Muscular Dystrophy
Cure Rare Disease
0
catalysts
Phase 3
CRD-1
cladribine
Myasthenia Gravis
Merck KGaA
0
catalysts
Phase 1
CRD-100
← prev
page 78 of 271
next →
131
Pain
89
Neurology
1
Angiosarcoma
Curadev Pharma Pvt Ltd
0
catalysts
Preclinical
CRG-01
Diabetic Retinopathy
CdmoGen Co Ltd
0
catalysts
Preclinical
CRG-02
Wet (Neovascular / Exudative) Macular Degeneration
CdmoGen Co Ltd
0
catalysts
Preclinical
CRHR1 Antagonists
Endometriosis
Sur180 Therapeutics LLC
0
catalysts
Phase 2
CRN-09682
Breast Cancer
$CRNX
Crinetics Pharmaceuticals, Inc.
0
catalysts
Preclinical
CRO-67
Pancreatic Cancer
Noxopharm Ltd
0
catalysts
Phase 2
CRS-3123
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Methionine--tRNA ligase
Crestone Inc
0
catalysts
Phase 1
CRX-100
Colorectal Cancer
BioEclipse Therapeutics Inc
0
catalysts
Preclinical
CS-01
memantine hydrochloride
Alzheimer's Disease
Center Laboratories Inc
0
catalysts
Phase 2
CS-0159
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Cascade Pharmaceuticals Inc
0
catalysts
Phase 2
CS-02
Type 2 Diabetes
Center Laboratories Inc
0
catalysts
Preclinical
CS-028
Pancreatic Cancer
Lumosa Therapeutics Co Ltd
0
catalysts
Phase 2
CS-1103
Substance (Drug) Abuse
Clear Scientific Inc
0
catalysts
Phase 1
CS-6253
Cogpep
Alzheimer's Disease
Artery Therapeutics Inc
0
catalysts
Preclinical
CSA-CFI
Pseudomonas aeruginosa Infections
Kinnear Pharmaceuticals LLC
0
catalysts
Phase 2
CSB-001
Neurotrophic Keratitis
Claris Biotherapeutics Inc
0
catalysts
Phase 1
CSL-404
Pandemic Influenza
$CSLLY
CSL LTD
0
catalysts
Preclinical
CSL-888
Subarachnoid Hemorrhage
$CSLLY
CSL LTD
0
catalysts
Preclinical
CSM-101
Parkinson's Disease
Casma Therapeutics Inc
0
catalysts
Phase 2
CST-3056
Neurogenic Orthostatic Hypotension (nOH)
CuraSen Therapeutics Inc
0
catalysts
Phase 1
CSTI-500
Prader-Willi Syndrome (PWS)
ConSynance Therapeutics Inc
0
catalysts
Preclinical
CT-010018
Alcohol Use Disorder (AUD)
TheraCryf plc
0
catalysts
Phase 2
CT-071
Plasma Cell Neoplasm
CARsgen Therapeutics Holdings Ltd
0
catalysts
Preclinical
CT-1001
Refractory Multiple Myeloma
Cure Therapeutics Co Ltd
0
catalysts
Phase 2
CT-101
Bone Fracture
$XAGE
Longevity Health Holdings, Inc.
0
catalysts
Preclinical
CT-262
Breast Cancer
Cairn Therapeutics Inc
0
catalysts
Phase 3
CT-388
Obesity
F. Hoffmann-La Roche Ltd
0
catalysts
